Literature DB >> 8682137

Platelet glycoprotein IIb/IIIa receptor antagonists in coronary artery disease.

J Lefkovits1, E J Topol.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8682137     DOI: 10.1093/oxfordjournals.eurheartj.a014698

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  8 in total

Review 1.  [Therapy of acute coronary syndrome. Aspirin, heparin, low-molecular-weight heparin, hirudin and GP-IIb/IIIa blockers].

Authors:  A Gaede; W Terres
Journal:  Herz       Date:  1999-08       Impact factor: 1.443

Review 2.  Incorporating platelet glycoprotein IIb/IIIa inhibition in critical pathways: unstable angina/non-ST-segment elevation myocardial infarction.

Authors:  C P Cannon
Journal:  Clin Cardiol       Date:  1999-08       Impact factor: 2.882

Review 3.  Avoidance of bleeding during surgery in patients receiving anticoagulant and/or antiplatelet therapy: pharmacokinetic and pharmacodynamic considerations.

Authors:  Sebastian Harder; Ute Klinkhardt; John M Alvarez
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

4.  Management of Acute Ischemic Coronary Syndromes: The Present and Future.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1998-11       Impact factor: 2.300

Review 5.  Abciximab. An updated review of its use in ischaemic heart disease.

Authors:  R H Foster; L R Wiseman
Journal:  Drugs       Date:  1998-10       Impact factor: 9.546

6.  The long-term clinical results of a platelet glycoprotein IIb/IIIa receptor blocker (Abciximab: Reopro) coated stent in patients with coronary artery disease.

Authors:  Weon Kim; Myung Ho Jeong; Young Joon Hong; Seng Hyun Lee; Woo Seok Park; Ju Han Kim; In Soo Kim; Myung Ja Choi; Young Keun Ahn; Jeong Gwan Cho; Jong Chun Park; Dong Lyun Cho; Hoon Kim; Jung Chaee Kang
Journal:  Korean J Intern Med       Date:  2004-12       Impact factor: 2.884

Review 7.  A bumpy and winding but right path to domestic drug-eluting coronary stents.

Authors:  Jae Yeong Cho; Youngkeun Ahn; Myung Ho Jeong
Journal:  Korean Circ J       Date:  2013-10       Impact factor: 3.243

8.  Anti-inflammatory effect of abciximab-coated stent in a porcine coronary restenosis model.

Authors:  Young Joon Hong; Myung Ho Jeong; Sang Rok Lee; Seo Na Hong; Kye Hun Kim; Hyung Wook Park; Ju Han Kim; Weon Kim; Youngkeun Ahn; Jeong Gwan Cho; Jong Chun Park; Jung Chaee Kang
Journal:  J Korean Med Sci       Date:  2007-10       Impact factor: 2.153

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.